All research
2026-07-15 PubMed

Neem-extract stabilized ZnO nanoparticles effectively treat avian pathogenic E. coli colibacillosis in broilers

Synthesis, characterization, and therapeutic evaluation of neem-extract stabilized zinc oxide nanoparticles against avian pathogenicEscherichia coliin broilers.

Background

The poultry industry faces significant challenges from colibacillosis, an infectious disease caused by avian pathogenic Escherichia coli. Widespread antibiotic use to combat this has fueled a global crisis of antimicrobial resistance, rendering many conventional treatments ineffective. This necessitates the urgent development of novel, non-antibiotic therapeutic strategies. Zinc oxide nanoparticles (ZnO-NPs) offer a promising alternative due to their inherent antimicrobial properties, and stabilization with natural extracts like neem can enhance their efficacy and biocompatibility.

Study Design

Researchers evaluated neem-extract stabilized ZnO-NPs in 100 one-day-old Cobb broiler chicks, randomly assigned to five groups (n=20). All groups except the negative control were intraperitoneally challenged with avian pathogenic E. coli (3 × 10^8 CFU/0.25 ml) at 10 days of age. Group G3 received colistin sulphate (1 g/5L drinking water), while Groups G4 and G5 were orally treated with 50 mg kg-1 and 70 mg kg-1 of neem-extract stabilized ZnO-NPs, respectively, over five days. Primary endpoints included agar-well diffusion assay for antibacterial activity, growth performance, mortality, serum biochemistry, and histopathology.

Results

Neem-extract stabilized ZnO-NPs demonstrated excellent in vitro antibacterial properties against avian pathogenic E. coli, with inhibition zones comparable to those achieved by colistin sulphate. In the in vivo broiler model, treated groups showed significantly better body weight gain and reduced mortality compared to the untreated infected group (p< 0.001). Biomarkers for liver and kidney function were also normalized after treatment, indicating improved hepatic and renal health. Histopathological examination revealed significant recovery of liver and kidney tissues, alongside a decrease in congestion and leukocytic infiltration, particularly pronounced in the 70 mg kg-1 ZnO-NP treatment group. This suggests a robust organ-protective effect.

The ZnO nanoparticles stabilized with neem extracts exhibited strong antibacterial and organ-protective effects against avian pathogenic E. coli infection in broilers, proving as effective as colistin sulphate.

Key Findings

  • Neem-extract stabilized ZnO-NPs showed in vitro antibacterial activity against E. coli comparable to colistin sulphate.
  • Treated broiler groups exhibited significantly better body weight gain and reduced mortality compared to untreated infected controls (p< 0.001).
  • Liver and kidney biomarkers normalized post-treatment, indicating improved hepatic and renal functioning.
  • Histopathological analysis revealed significant liver and kidney tissue recovery, with reduced congestion and leukocytic infiltration, especially at 70 mg kg-1 ZnO-NPs.

Why It Matters

This study presents a compelling, non-antibiotic alternative for managing colibacillosis in poultry, directly addressing the critical issue of antimicrobial resistance. Adopting neem-extract stabilized ZnO-NPs could significantly reduce reliance on conventional antibiotics in broiler production, potentially improving animal welfare and food safety. While currently a preclinical animal study, the clear efficacy and organ-protective effects observed suggest a promising path toward a usable protocol for large-scale poultry farming. Further research is needed to optimize dosing, assess long-term safety, and explore potential applications in other livestock, but the immediate impact on poultry health could be substantial.


zinc oxide nanoparticles neem extract escherichia coli colibacillosis broilers poultry
Source: pubmed:42454440 · Ingested 2026-07-15 · Digest: gemini-2.5-flash